Vi announced the launch of a new suite of vertically specialized AI agents designed for healthcare, life sciences, and wellness enterprises. The company also confirmed the completion of a $145 million transaction that valued the company at $1.64 billion.
The new AI agents are integrated across Vi’s Activate, Engage, and Operate applications and are designed to function as an AI execution layer for healthcare and wellness organizations. According to the company, the agents support next-best actions across patients, care teams, and operational workflows.
Vi said the AI agents are powered by its proprietary Data Web, which the company describes as one of the world’s largest datasets of clinical, behavioral, and operational signals. The platform enables real-time decision-making and supports use cases including patient care navigation, physician next-best actions, clinical trial acceleration, drug commercialization, and operational optimization.
The company said it currently serves more than 100 enterprise customers, has helped bring over 50 drugs to market, supports more than 190 million lives, and has generated more than $2 billion in measurable value across its partner ecosystem.
Vi also announced that it completed a $145 million transaction consisting of both primary and secondary capital. The company said the funding will be used to support talent retention and recruitment, expand its platform and product offerings, and strengthen its balance sheet.
The company’s shareholders include General Atlantic, Revelstoke, 1902 Capital, Square Peg, Savano Capital, and Island Green.
KEY QUOTES:
“Vi believes health abundance in our lifetime is possible, a future in which every person, regardless of wealth or geography, has access to the most precise, predictive, and affordable care medicine can deliver.”
Vi Labs
